Paul Gitman, Director at BIOSPECIFICS TECHNOLOGIES CORP (BSTC), sold 8,692 shares at $53.00 ($461K) on 2015-07-20, disclosed to the SEC on 2015-07-21.
Scheduled sale ($461k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BSTC | SELL | 2018-08-29 | $945K | — | Filing → |
| BSTC | SELL | 2018-08-29 | $883K | — | Filing → |
| BSTC | SELL | 2015-06-25 | $1.9M | — | Filing → |